A preterm birth can happen to any pregnancy

1 in 10 babies are born too soon.

The emotional, financial and long-term health implications for baby and family can be overwhelming. Until now, ways to accurately predict the risk have been limited, with only a small percentage of premature births identified.

Learn More About Healthier Outcomes
white women holding her belly with two hands
male holding women's belly up from behind

The PreTRM® Test is the first of its kind for premature birth

This leading-edge predictive test identifies a pregnant patient’s risk of spontaneous preterm birth to improve outcomes, even if they lack evident risk factors. The PreTRM® Test is the only clinically validated commercially available blood test that provides an early, individual risk assessment for spontaneous preterm birth in asymptomatic, singleton pregnancies.

Learn more about how your practice can get started
headshot photo of a doctor in surgery black women holding her baby and smiling Headshot of a women

Together,
we can do better

  • Healthcare Providers
  • Moms
  • Payers and Employers

Healthcare Providers

Working together we can address problems of preterm birth. Our advances in science identify more pregnancies that may be at higher risk, giving physicians and mothers more control to manage each individual’s risk of spontaneous preterm birth, and give babies the best possible care in life.

Healthcare Provider Insights

Moms

Understanding if your pregnancy is at higher risk for spontaneous preterm birth allows you and your physician to adjust your treatment plans accordingly. Learn more about the importance of knowing your risk for preterm birth.

learn more

Payers and Employers

Working together, we can address the problem of preterm birth. Advances in science now provide critical information to improve the health and economic impacts of early deliveries.

Learn More

Each Day Matters

Each day in the womb is critical for baby’s health and development

The PreTRM® Test is a new tool providers and their patients can use to identify and address those at higher risk to improve outcomes. The AVERT PRETERM Trial demonstrated a significant reduction in the time the baby spent in the hospital and an 18% reduction in severe neonatal morbidity and mortality when higher-risk pregnancies identified by the PreTRM Test received risk-reduction interventions compared to standard care.2

Learn More about Womb vs. NICU

Planning Early

Each day in the womb is critical for baby’s health and development.

How to get the test
38 Calendar Event Solid@250×250

References

    1. Iams, JD, et al. Prevention of preterm parturition. N Engl J Med. 2014;370:254-61. Sitar T, et al. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins. Proc Natl Acad Sci USA. 2006 103: 13028-13033.
    2. Matthew K. Hoffman, Carrie Kitto, Zugui Zhang, et al. Neonatal outcomes after proteomic biomarker-guided intervention: the AVERT PRETERM TRIAL. medRxiv 2023.09.13.23295503; doi: https://doi.org/10.1101/2023.09.13.23295503